Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating promising results in the treatment of type 2 diabetes. This synthetic peptide mimics the actions of naturally present GLP-1, a hormone https://bookmarkleader.com/story20856051/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes